Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injuryJiahua Xie,Farooqahmed S.Kittur,P.Andy Li,Chiu-Yueh Hung1397-1403
Microglia activation, classification and microglia-mediated neuroinflammatory modulators in subarachnoid hemorrhageJunfan Chen,Zhiyuan Vera Zheng,Gang Lu,Wai Yee Chan,Yisen Zhang,George Kwok Chu Wong1404-1411
MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer 's disease and amyotrophic lateral sclerosisBridget Martinez,Philip V.Peplow1412-1422
Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementiaSantiago E.Charif,M.Florencia Vassallu,Lara Salva?al,Lionel M.Igaz1423-1430
A novel viewpoint in glaucoma therapeutics: enriched environmentMaría F.González Fleitas,Damián Dorfman,Ruth E.Rosenstein1431-1439
The role of L-arginine metabolism in neurocritical care patientsMarius Marc-Daniel Mader,Patrick Czorlich1446-1453
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesionsXiu-Quan Wu,Ning Su,Zhou Fei,Fei Fei1454-1461
Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinicJames A.Conway,Edgar R.Kramer1462-1467